Drug intelligence / Profile preview

Ershiwuwei Shanhua Wan

Development stage
Unknown
Lead developer
The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine
Modality
Small Molecules
Administration
Oral
01

Overview

Ershiwuwei Shanhua Wan, also known as the Twenty-Five-Flavor Coral Pill, is a traditional Tibetan medicine (TTM) formulation widely utilized for the treatment of neurological and cerebrovascular disorders. It is composed of 25 distinct ingredients, including precious minerals like coral and pearl, and botanical components such as saffron and musk. The formulation is primarily indicated for cerebral infarction (stroke), hypertension, epilepsy, and various forms of headache or neuritis. Pharmacologically, it is thought to exert neuroprotective effects by improving cerebral microcirculation, reducing oxidative stress, and inhibiting neuronal apoptosis. In the context of Tibetan medicine, it is used to clear heat and tranquilize the mind, specifically targeting rLung (wind) imbalances that affect the nervous system. The drug is manufactured by several prominent Tibetan pharmaceutical companies and has been the subject of clinical research at institutions such as The Third Affiliated Hospital of Beijing University of Traditional Chinese Medicine.

Brand names
CheezhengGanlu
Other names
twenty-five-flavor coral pill25-flavor coral pilltwenty-five-wei coral pillErshiwuwei Shanhua Pills

Beyond the preview

Go deeper on Ershiwuwei Shanhua Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ershiwuwei Shanhua Wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call